Robert Wodtke
Dresden, SN 01328, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin.
Journal: Molecules (Basel, Switzerland)
Published: April 30, 2026
Radioiodination of Two Carborane-Based Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation.
Journal: Chembiochem : a European journal of chemical biology
Published: January 14, 2026
Development of Cathepsin B‑Activatable Cell-Penetrating Peptides for Tumor Targeting.
Journal: ACS pharmacology & translational science
Published: November 14, 2025
"Precision on Two Wheels"─Structural Refinement of 64Cu- and 68Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human Application.
Journal: Journal of medicinal chemistry
Published: October 13, 2025
In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 01, 2025
Deciphering the Tumor Uptake of Heterobivalent (SST2/Albumin) [64Cu]Cu-NODAGA-cLAB-TATEs.
Journal: Journal of medicinal chemistry
Published: May 20, 2025
Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al18F/68Ga/111In.
Journal: Bioconjugate chemistry
Published: August 26, 2024
The heterobivalent (SSTR2/albumin) radioligand [67Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics.
Journal: Theranostics
Published: June 25, 2024
Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2.
Journal: EJNMMI radiopharmacy and chemistry
Published: November 06, 2023
Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging.
Journal: ChemMedChem
Published: June 28, 2023
Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins.
Journal: Journal of medicinal chemistry
Published: March 03, 2023
Last Updated: 09/26/2026